Campaigners in Northern Ireland have called for the introduction of a 'game-changing' drug that will prevent HIV. On Friday ...

The UK has approved a long-acting HIV jab that requires just one injection every two months. Doctors call it a breakthrough ...

With figures showing heterosexuals to be most at risk of contracting the virus, Anne Aslett says it’s time ‘pre-exposure’ ...

The injection, known as cabotegravir, is a form of pre-exposure prophylaxis (PrEP) and is administered every two months.

New guidance also spans prevention, screening, vaccines, mental health, and HIV-2, and is designed to help clinics manage older patients with complex needs.

EACS 2025 data show over half of HIV diagnoses among migrants in Switzerland occur post-migration, highlighting need for ...

More than half of all new HIV diagnoses among migrants in Switzerland occur years after they have relocated, according to ...

Source: ‘Miracle’ HIV shot rollout in Zimbabwe sparks debate – DW – 10/16/2025 Zimbabwe is among 10 nations rolling out ...

The National Council for HIV and AIDS (CONAVIHSIDA) announced that an estimated 87,000 people are currently living with HIV ...

In a memo, the state health department explained the new restrictions are the result of an “unprecedented increase in program ...

NICE has recommended cabotegravir, the UK’s first long-acting injectable HIV prevention drug, expanding access for people unable to take daily tablets.

A twice-yearly HIV prevention injection, lenacapavir, marketed in the United States as Yeztugo by Gilead Sciences, is generating mixed reactions among Nigerians following reports that it could soon be ...